top of page
Research Findings
Neudive Obtains Digital Medical Device Manufacturing License
Neudive Co., Ltd. has received a digital medical device manufacturing license from the Ministry of Food and Drug Safety.
NDTx-01 Exploratory Clinical Trial Results Published in SCIE-Indexed Journal
Neudive Co., Ltd. successfully completed an exploratory clinical trial to verify the initial safety and efficacy of NDTx-01 (Buddy-in), developed to improve social communication and interaction in children and adolescents (ages 10–18) with Autism Spectrum Disorder (ASD) or Social Communication Disorder (SCD). The results of the exploratory clinical trial were published on April 11, 2025 in Psychiatry and Clinical Neurosciences, an SCIE-indexed academic journal. https://online
Neudive NDTx-01 Designated as Innovative Medical Device (General)
NDTx-01 (Buddy-in), developed by Neudive Co., Ltd. to improve social communication and interaction in children and adolescents (ages 10–18) with Autism Spectrum Disorder (ASD) or Social Communication Disorder (SCD), was recognized for its scientific and clinical excellence and designated as an Innovative Medical Device (General) by the Ministry of Food and Drug Safety on January 14, 2025. https://emedi.mfds.go.kr/brd/view/MNU20255searchType=ALL&pageNum=2&&n…
bottom of page